These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17042914)

  • 21. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats.
    Inan M; Basaran U; Dokmeci D; Kanter M; Yalcin O; Aydogdu N; Turan N
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):457-61. PubMed ID: 17439415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia.
    Sheu WH; Chuang HC; Cheng SM; Lee MR; Chou CC; Cheng FC
    J Pharm Biomed Anal; 2011 Mar; 54(4):759-64. PubMed ID: 21055895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPAR-gamma: therapeutic target for ischemic stroke.
    Culman J; Zhao Y; Gohlke P; Herdegen T
    Trends Pharmacol Sci; 2007 May; 28(5):244-9. PubMed ID: 17416424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
    Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.
    Chen C; Xu S; Wang WX; Ding YM; Yu KH; Wang B; Chen XY
    Arch Med Res; 2009 Feb; 40(2):79-88. PubMed ID: 19237016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
    Celiński K; Madro A; Prozorow-Król B; Korolczuk A; Cichoz-Lach H; Słomka M; Korobowicz E
    Med Sci Monit; 2009 Jan; 15(1):BR21-9. PubMed ID: 19114961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
    Vakili A; Hosseinzadeh F; Sadogh T
    Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
    Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR
    Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model.
    Aytan H; Caliskan AC; Demirturk F; Aytan P; Koseoglu DR
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):321-5. PubMed ID: 17627689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
    Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
    Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs.
    Sener G; Sehirli AO; Gedik N; Dülger GA
    Burns; 2007 Aug; 33(5):587-93. PubMed ID: 17467912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
    Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
    Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
    Shuaib A; Xu Wang C; Yang T; Noor R
    Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic hyperthermia masks the neuroprotective effects of MK-801, but not rosiglitazone in brain ischaemia.
    Nategh M; Shaveisi K; Shabanzadeh AP; Sadr SSh; Parviz M; Ghabaei M
    Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):724-9. PubMed ID: 20406202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.